ORGANOGENESIS HOLDINGS INC.

ORGO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016
Operating Activities
Net Income $-8.4M $-17.0M
Depreciation & Amortization
Depreciation $3.6M $5.7M
Amortization $2.0M $1.6M
Stock-Based Compensation $919.0K $473.0K
Net Cash from Operating Activities $-3.5M $-4.9M
Investing Activities
Capital Expenditures $2.4M $1.4M
Business Acquisitions $11.8M
Net Cash from Investing Activities $-14.9M $-1.2M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $18.9M $6.8M
Net Change in Cash $-914.2K $914.0K
Free Cash Flow $-5.9M $-6.2M
← Newer Page 2 of 2 Older →